Navigation Links
Pharmaxis Announces New Drug Application Submission for Aridol(TM)
Date:3/1/2009

SYDNEY, March 1 /PRNewswire-Asia-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS, Nasdaq: PXSL) today announced it had submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Aridol, a bronchial challenge test. Bronchial challenge tests are designed to help in the correct diagnosis and assessment of asthma. The structure and content of the NDA was based on a pre-NDA meeting with the FDA and follows the completion of two international randomized pivotal Phase 3 trials with Aridol involving over 1,000 subjects.

The NDA application is the vehicle through which Pharmaxis formally proposes that the FDA approve a new pharmaceutical for sale and marketing in the U.S. There is currently no FDA approved dry powder bronchial challenge test available in the U.S. and Aridol is the first test of this kind that comes complete and ready to use.

Alan Robertson, Pharmaxis Chief Executive Officer said: "We are delighted to announce this major milestone for Pharmaxis especially in light of the fact that this is believed to be the first such NDA submitted by an Australian company for a drug designed and developed in Australia. Pharmaxis is committed to the development of safe and effective products to help people living with lung diseases, and we look forward to working closely with the FDA over the coming months."

Asthma affects more than 34 million people in the U.S.(1) with an annual economic cost in the U.S. of $19.7 billion(1) and has a substantial impact on the health of a nation. Aridol was developed to assist with improving existing management strategies that help to control asthma and prevent worsening of its symptoms.

Aridol is approved for sale in most major European countries, Australia and Korea. Aridol has been included in the Global Initiative for Asthma
'/>"/>

SOURCE Pharmaxis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmaxis Long-Term Safety Study of Bronchitol Completes
2. Pharmaxis Establishes Named Patient Program for Bronchitol
3. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
4. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today ... second quarter 2014 financial results before the NASDAQ Global ... same day, Arena will host a conference call and ... Time). The conference call may be ... for international callers. Please specify to the operator that ...
(Date:7/24/2014)... , July 24, 2014  PTC Therapeutics, Inc. (NASDAQ: ... will host a webcast conference call to report its ... on the company,s business and outlook on Thursday, August ... of the market. The call can ... 935-8152 (international) five minutes prior to the start of ...
(Date:7/24/2014)...  Uroplasty, Inc. (NASDAQ: UPI ), a ... innovative proprietary products to treat voiding dysfunctions, today ... quarter ended June 30, 2014.  Global revenue ... grew 19% to $4.1 million, as compared to ... prior year.  Total revenue for the fiscal first ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11
... PRINCETON, N.J., April 28, 2011 Pharmasset, Inc. (Nasdaq: ... Deutsche Bank Healthcare Conference being held May 2 to 4, ... Bank of America Merrill Lynch Healthcare Conference being held May ... Vegas, NV. Schaefer Price, Pharmasset,s President and Chief Executive Officer, ...
... SILVER SPRING, Md., April 28, 2011 The ... (abiraterone acetate) in combination with prednisone (a steroid) ... cancer who have received prior docetaxel (chemotherapy). ... prostate cancer, the male sex hormone testosterone stimulates ...
Cached Medicine Technology:Pharmasset to Present at Two Upcoming Investor Conferences 2Pharmasset to Present at Two Upcoming Investor Conferences 3FDA Approves Zytiga for Late-Stage Prostate Cancer 2FDA Approves Zytiga for Late-Stage Prostate Cancer 3
(Date:7/28/2014)... According to the Heartburn No More PDF review recently ... help people get rid of acid reflux naturally. ... heartburn and acid reflux. In addition, inside this book, people ... factors for reflux disease. , Vkool informs in its ... symptoms of reflux disease naturally without medications. The book also ...
(Date:7/28/2014)... Angeles, Calif., July 27, 2014 - (PRWEB) July 28, 2014 ... title in 12 months by earning the Masters Champion title ... 20, proving that age is no obstacle for this athlete. ... win at the event hosted by the International Pole Sports ... to 63, traveling from 30 countries, took part in the ...
(Date:7/28/2014)... Cuidado Casero , an organization of ... and PHC in Texas, New Mexico, New Jersey, Virginia, and ... North Texas Chapter of PAM’s 2014 Gala. , North ... Society. The North Texas chapter was created by a handful ... in improving medical care for the indigent in Peru. The ...
(Date:7/27/2014)... July 27, 2014 Manufacturers of natural ... organic ways to achieve a younger appearance. The Cherry ... guide to help men and women explore the availabilities ... details that are presented in the posted guide on ... information for consumers. On drawback to some natural ingredient ...
(Date:7/27/2014)... scientists have shown that a powerful drug given at ... halves the early risk of rejection, but that it ... to be used after the operation. , The key ... presented at the World Transplant Congress in San Francisco ... transplant conundrum: the powerful combinations of treatments used to ...
Breaking Medicine News(10 mins):Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 3Health News:Inspiring Senior Athlete Lands Third World Title in One Year 2Health News:Cuidado Casero Sponsors Peruvian American Medical Society (PAMS) Gala 2Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 2Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 3
... Smoking Cessation Expert Franc Tausch is launching the Stop ... event quit smoking in one day, without nicotine withdrawal or weight ... ... Radio Personality Franc Tausch, who was last heard on the popular Talk ...
... PCI continues to closely monitor the swine flu outbreak both in ... in San Diego. Since Thursday, PCI staff in San Diego, ... growing health issue, as we determine our organizational priorities and focus ... for the greatest number of people. , ...
... Iowa, April 28 The flu virus infecting humans has ... or anywhere in the world. , , ... said, "At this time, there is no evidence that this influenza subtype is ... in the world." , The CDC ...
... 28 American Life League,s president, Judie Brown, ... confirmation, 65 - 31, of Gov. Kathleen Sebelius ... Human Services. Sebelius received the support of Kansas ... pro-life leaders.(Logo: http://www.newscom.com/cgi-bin/prnh/20081105/DC44231LOGO ...
... Judges and attorneys from around the country handling thousands ... June 3 for a conference and webcast on effectively ... of asbestos trusts.The program - entitled the "Judicial Forum ... Conferences LLC, formerly Mealey,s Conferences.The chairmen are Perry Weitz ...
... Epilepsy Foundation applauds legendary rock star Prince for sharing his ... PBS,s Tavis Smiley show . The award-winning ... young and my mother and father didn,t know what to ... best they could with what little they had."Prince said he ...
Cached Medicine News:Health News:Renowned Smoking Cessation Expert Launches Popular Stop Smoking Seminar in UK 2Health News:PCI's Response to Swine Flu Evolves to Keep Pace with Emerging Health Threat 2Health News:National Pork Board Provides Facts About the Origin of the Flu Outbreak 2Health News:American Life League: 'Pro-Life' Senators Appoint Radically Pro-Abortion Sebelius as H.H.S. Secretary 2Health News:Asbestos Judges, Attorneys Holding Judicial Forum June 3 2Health News:The Epilepsy Foundation Commends Rock Star Prince for Talking About It 2
... Katena Products, Inc. is the ... dedicated exclusively to ophthalmic surgical ... to over 7,000 customers in ... a global network of distributors, ...
... Studies have proven that the management of ... blood glucose levels is the most effective way ... comprehensive care aimed at maintaining or improving a ... complex and costly. , ,These have been ...
... intended for detecting trends and tracking patterns ... and older) and children/adolescents (aged 7 to ... use of the G2 Biographer with their ... supplement, not replace, conventional blood glucose monitoring. ...
... Ex-PRESS is a mini ... simplified,method of filtration surgery for ... to trabeculectomy, the shunt reduces ... aqueous humor from the anterior ...
Medicine Products: